1,9 %Subtype H accounted for 1.9% of HIV-1 cases in the studied population in Gabon.
GabonVIH/sidapublié 2012BMC Infectious DiseasesOpenAlexdocument de 14 observationsDOI 10.1186/1471-2334-12-64
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
242 evidences · page 6 / 10
1,9 %Subtype H accounted for 1.9% of HIV-1 cases in the studied population in Gabon.
GabonVIH/sidapublié 2012BMC Infectious DiseasesOpenAlexdocument de 14 observationsDOI 10.1186/1471-2334-12-64
54 %Half of the HIV-positive women (54%) started their antenatal antiretroviral prophylaxis initiation during the second trimester of pregnancy.
GabonVIH/sidapublié 2018International journal of STD & AIDSPubMeddocument de 5 observations
378 casesAmong 1300 pregnant women tested for HIV at Saint Camille Medical Centre from September 2010 to July 2011, 378 were seropositive.
GabonVIH/sidaobservé September 2010 to July 2011publié 2012Asian Pacific journal of tropical medicineeurope_pmcdocument de 2 observations
20,8 %HPV-30'S prevalence among HIV-infected women in Ouagadougou was 20.8%.
GabonHPV-30'S · VIH/sidaobservé 2009–2010publié 2011Acta tropicaeurope_pmcdocument de 8 observations
24,6 %One-quarter (24.6%) of study children experienced full therapeutic failure with immunological and virological nonresponses.
GabonVIH/sidapublié 2020Journal of clinical medicine researchPubMeddocument de 4 observations
42 %In Lambaréné, Gabon, the HIV coinfection rate among adult TB patients was 42% between 2012 and 2014.
Gabontuberculose · VIH/sidaobservé 2012 and 2014publié 2016The American journal of tropical medicine and hygieneeurope_pmcdocument de 12 observationsDOI 10.4269/ajtmh.15-0668
6 fold_higher_riskWomen living with human immunodeficiency virus (WLWH) have a six-fold higher risk of developing cervical cancer associated with high-risk human Papillomavirus (HR-HPV) than HIV-negative women.
Gaboncancer du col de l'utérus · high-risk human papillomavirus · VIH/sidapublié 2025Diseases (Basel, Switzerland)PubMeddocument de 12 observations
4,3 %Among hospitalised PLHIV with tuberculosis, 4.3% had extra-pulmonary disseminated tuberculosis.
Gabontuberculose · VIH/sidaobservé 2021-2022publié 2025Southern African journal of infectious diseaseseurope_pmcdocument de 11 observationsDOI 10.4102/sajid.v40i1.695
0 %The rate of vertical transmission of HIV was 0.0% (0/115) among HIV-positive pregnant women at Saint Camille Medical Centre.
GabonVIH/sidapublié 2010The Brazilian journal of infectious diseases : an official publication of the Brazilian Soeurope_pmcdocument de 6 observations
2 %Less than 2% of the 62 HIV-2 patients were in WHO stage IV.
GabonVIH/sidaobservé 2003-2013publié 2014Pakistan journal of biological sciences : PJBSeurope_pmcdocument de 8 observations
666 samplesSix hundred and sixty-six plasma samples from people living with HIV were collected and analyzed for resistance mutations in Gabon.
GabonVIH/sidaobservé October 2019 to October 2022publié 2025Tropical medicine and infectious diseasePubMeddocument de 5 observations
8,9 %The overall prevalence of HIV infection in infants born from infected mothers was 8.9%.
GabonVIH/sidapublié 2018International journal of STD & AIDSPubMeddocument de 5 observations
48,2 %Severe malaria was significantly more common among HIV-positive patients (48.2%) than among HIV-negative patients (12.1%).
Gabonpaludisme · VIH/sidaobservé 2021 to 2022publié 2026PloS onePubMeddocument de 11 observations
0,3 p-valueThe genetic diversity of HIV-1 had no significant effect on the residual risk in blood transfusion (CRF02_AG, P = 0.3 and Recombinants, P = 0.5).
GabonVIH/sidaobservé 2020-08-03 to 2021-08-31publié 2024PloS onePubMeddocument de 4 observations
9 casesNine of 84 women (11%) were HIV-positive.
GabonVIH/sidaobservé March 2023-March 2024publié 2025IJID regionsPubMeddocument de 7 observations
6,2 %Among 16 sequenced HIV-1 samples, subtype F2 accounted for 6.2% of strains.
Gabonsubtype F2 · VIH/sidaobservé 2020–2021publié 2023BMC infectious diseasesPubMeddocument de 8 observations
3 log10_copies_per_mlMean HIV-1 viral load was Log 3.0 (± 1.6) copies/ml in HIV-1 mono-infected individuals.
GabonVIH/sidapublié 2022PloS onePubMeddocument de 12 observations
24,02 %The treatment regimen TDF + 3TC + EFV was prescribed to 24.02% (160 out of 666) of the studied people living with HIV in Gabon.
GabonVIH/sidaobservé October 2019 to October 2022publié 2025Tropical medicine and infectious diseasePubMeddocument de 5 observations
66,7 %About two-thirds of the 62 HIV-2 patients had a CD4 count below 250 cells/mm³.
GabonVIH/sidaobservé 2003-2013publié 2014Pakistan journal of biological sciences : PJBSeurope_pmcdocument de 8 observations
2,37 odds_ratioA CD4 haplotype rs11575097-rs10849523 is associated with high HIV-2 plasma viral load, with an odds ratio of 2.37.
GabonVIH/sidapublié 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 3 observationsDOI 10.1097/qai.0b013e3181f638ed
46,7 %The treatment success rate in individuals co-infected with HIV and tuberculosis was 46.7%.
Gabontuberculose · VIH/sidaobservé 2022 to 2023publié 2025IJID regionsPubMeddocument de 9 observations
14 casesAt Saint Camille Medical Centre, among 115 HIV-positive pregnant women, 14 were coinfected with HBV.
Gabonhépatite B · VIH/sidapublié 2010The Brazilian journal of infectious diseases : an official publication of the Brazilian Soeurope_pmcdocument de 6 observations
25 %Among the samples successfully sequenced, four participants had major drug resistance mutations, giving a pre-treatment drug resistance (PDR) threshold of 25% (4/16).
GabonVIH/sidaobservé 2020-08-03 to 2021-08-31publié 2024PloS onePubMeddocument de 4 observations
46,7 %The main HIV-1 subtype circulating among the studied population in Gabon was recombinant CRF02_AG, accounting for 46.7% of cases.
GabonVIH/sidapublié 2012BMC Infectious DiseasesOpenAlexdocument de 14 observationsDOI 10.1186/1471-2334-12-64
14,3 %Severe anaemia occurred in 14.3% of PLHIV with malaria.
Gabonpaludisme · VIH/sidaobservé 2021 to 2022publié 2026PloS onePubMeddocument de 11 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.